Cargando…
External validation of a prognostic model based on total tumor load of sentinel lymph node for early breast cancer patients
BACKGROUND: A prognostic model based on the results of molecular analysis of sentinel lymph nodes (SLN) is needed to replace the information that staging the entire axilla provided. The aim of the study is to conduct an external validation of a previously developed model for the prediction of 5-year...
Autores principales: | Piñero-Madrona, Antonio, Ripoll-Orts, Francisco, Sánchez-Méndez, José Ignacio, Chaves-Benito, Asunción, Gómez-de la Bárcena, Maximiliano Rodrigo, Calatrava-Fons, Ana, Menjón-Beltrán, Salomón, Peg-Cámara, Vicente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188708/ https://www.ncbi.nlm.nih.gov/pubmed/32253684 http://dx.doi.org/10.1007/s10549-020-05623-4 |
Ejemplares similares
-
The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
por: de Boniface, Jana, et al.
Publicado: (2020) -
Sentinel lymph node biopsy of the internal mammary chain in breast cancer
por: Postma, E. L., et al.
Publicado: (2012) -
Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
por: van Roozendaal, L. M., et al.
Publicado: (2016) -
Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer
por: Dixon, J. Michael, et al.
Publicado: (2020) -
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment
por: Tinterri, Corrado, et al.
Publicado: (2023)